Inventory control of expensive injection drugs is highly important in hospital management, and careful handling of highrisk drugs is required to ensure safety in drug therapy. In this regard, when a hospital determines appropriate content sizes to be adopted in the case of drugs available in many different vial sizes, it is necessary to weigh costs against risk management, especially for anti-cancer drugs since they are not only expensive but also highly hazardous. Therefore, the establishment of an adoption strategy for these drugs is a prerequisite for efficient hospital management and safety of drug therapy. This study looked at an appropriate drug size adoption strategy for anticancer chemotherapeutics at Asahikawa Medical University based the following approach: 1) determine the motives for increasing or decreasing the number of drugs purchased in multiple vial sizes, 2) examine the expected effects of each motive, 3) determine the greatest effect by evaluation of drug properties, 4) in evaluation obtain score for each property and 5) determine appropriate adoption priority indices. A review of the vial sizes adopted based on this approach showed that it would reduce patient co-payments as well as hospital expenses without compromising safety or operational procedures. Therefore, an effective drug adoption strategy based on individual drug characteristics and available sizes could achieve greater safety and efficiency in hospital management.

